UPDATE : Monday, September 7, 2020
상단여백
Korea to spend ₩1 trillion on fight against infectious diseases by Shim Hyun-tai 2020-06-03 18:18
[ASCO 2020 ④] MedPacto's Vactosertib combo treatment for desmoid tumors proved safe by Shim Hyun-tai 2020-06-03 17:20
Unrelenting church-linked infections raise worries about new viral wave by Shim Hyun-tai 2020-06-03 12:34
‘Mental, behavioral disorders’ social costs larger than their medical expense’ by Shim Hyun-tai 2020-06-02 18:28
[ASCO 2020 ③] Genexine’s combo therapy for breast cancer proves safety by Shim Hyun-tai 2020-06-02 17:14
라인
Resurge of church-linked virus cases dims outlook for broader school reopening by Shim Hyun-tai 2020-06-02 14:45
Huons to supply emergency drugs to global market by Shim Hyun-tai 2020-06-01 15:26
Korea wrestles with sporadic cluster infections, out-of-route spreads by Shim Hyun-tai 2020-06-01 13:09
Researchers find key for arthritis recovery by Shim Hyun-tai 2020-05-29 18:01
Korea goes all out to contain infections in Seoul metro region by Shim Hyun-tai 2020-05-29 16:54
라인
New SW diagnoses rare diseases in infants swiftly by Shim Hyun-tai 2020-05-28 18:18
Doctors group moves toward eliminating unlicensed practices by Shim Hyun-tai 2020-05-28 16:23
Resurge of new virus cases may force Korea to return to social distancing by Shim Hyun-tai 2020-05-28 12:42
Patch developed for swift, accurate diagnosis of pregnancy toxemia by Shim Hyun-tai 2020-05-27 17:56
'Hypertension drug has no adverse effects on Covid-19 patients' by Shim Hyun-tai 2020-05-27 17:11
라인
New virus cases rebound amid persistent cluster infections by Shim Hyun-tai 2020-05-27 14:26
Druggists oppose government moves toward telemedicine by Shim Hyun-tai 2020-05-26 20:16
MSD-Eisai combo therapy wins nod as indication for endometrial cancer by Shim Hyun-tai 2020-05-26 17:30
‘GSK's Synflorix prevents ear infection more effectively than PCV13’ by Shim Hyun-tai 2020-05-26 17:26
Club-linked cases continue ahead of additional school reopening by Shim Hyun-tai 2020-05-26 13:56
여백
여백
여백
Back to Top